糖尿病病的治疗方法. 一个网络元分析
Fabian Büttner1, Clara Vollmer Barbosa1, Hannah Lang1
1Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
PloS one
|November 2, 2023
概括
-葡萄糖携带载体-2 抑制剂 (SGLT2i) 在糖尿病病 (DKD) 患者中显著降低死亡率和末期病进展. 非类固醇矿物质皮质类受体对抗剂 (nsMRA) 也显示出对脏的益处,没有安全问题.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病病 (DKD) 是一个日益严重的全球健康问题.
- 减缓DKD进展到末期病 (ESKD) 是主要的治疗目标.
- 目前对DKD的药物治疗需要进行比较分析.
研究的目的:
- 系统地审查和网络分析DKD的药物治疗方法.
- 为了比较各种药物类别在管理DKD时的疗效和安全性.
- 确定最佳的药理策略来减缓DKD的进展.
主要方法:
- 随机对照试验的系统审查和网络元分析.
- 包括单个ACEi/ARB,ACEi+ARB组合,阿尔多激素对抗剂,直接宁抑制剂,nsMRA和SGLT2i的研究.
- 主要终点:整体死亡率,ESKD;次要终点:脏复合结果,白蛋白尿;安全终点:AKI,高血,低血压.
主要成果:
- -葡萄糖携带载体-2 抑制剂 (SGLT2i),当添加到单个ACEi/ARB时,显著降低死亡率 (OR 0.81) 和ESKD (OR 0.69).
- 对于复合性脏终点 (OR 0.60),SGLT2i表现出优于非类固醇矿物质皮质醇受体对抗剂 (nsMRA) 的优势.
- 与其他干预措施相比,nsMRA和SGLT2i表现出有利的安全概况.
结论:
- 作为ACEi/ARB的附加疗法,SGLT2i是经过验证的DKD治疗方法,可以改善存活率并减缓病的进展.
- nsMRA有效地减少综合结果,而不会引起安全问题,支持它们在DKD管理中的使用.
- 对比分析证实SGLT2i是DKD的关键治疗选择,nsMRA提供额外的益.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
13
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
13
01:25Chronic Kidney Disease I: Introduction
17
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
17
01:20Acute Kidney Injury V: Interprofessional Care
11
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
11
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
18
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
18
01:18Chronic Kidney Disease IV: Nursing Management
9
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
9
01:28Kidney Transplant I: Introduction
14
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
14